IBDEI1OE ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30107,1,3,0)
 ;;=3^Malig Neop Anal Skin
 ;;^UTILITY(U,$J,358.3,30107,1,4,0)
 ;;=4^C44.500
 ;;^UTILITY(U,$J,358.3,30107,2)
 ;;=^5001051
 ;;^UTILITY(U,$J,358.3,30108,0)
 ;;=C44.509^^189^1906^13
 ;;^UTILITY(U,$J,358.3,30108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30108,1,3,0)
 ;;=3^Malig Neop of Skin of Trunk NEC
 ;;^UTILITY(U,$J,358.3,30108,1,4,0)
 ;;=4^C44.509
 ;;^UTILITY(U,$J,358.3,30108,2)
 ;;=^5001053
 ;;^UTILITY(U,$J,358.3,30109,0)
 ;;=D25.9^^189^1906^11
 ;;^UTILITY(U,$J,358.3,30109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30109,1,3,0)
 ;;=3^Leiomyoma of Uterus,Unspec
 ;;^UTILITY(U,$J,358.3,30109,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,30109,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,30110,0)
 ;;=N39.3^^189^1906^18
 ;;^UTILITY(U,$J,358.3,30110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30110,1,3,0)
 ;;=3^Stress Incontinence
 ;;^UTILITY(U,$J,358.3,30110,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,30110,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,30111,0)
 ;;=N76.0^^189^1906^3
 ;;^UTILITY(U,$J,358.3,30111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30111,1,3,0)
 ;;=3^Acute Vaginitis
 ;;^UTILITY(U,$J,358.3,30111,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,30111,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,30112,0)
 ;;=N76.1^^189^1906^19
 ;;^UTILITY(U,$J,358.3,30112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30112,1,3,0)
 ;;=3^Subacute/Chronic Vaginitis
 ;;^UTILITY(U,$J,358.3,30112,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,30112,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,30113,0)
 ;;=N76.2^^189^1906^4
 ;;^UTILITY(U,$J,358.3,30113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30113,1,3,0)
 ;;=3^Acute Vulvitis
 ;;^UTILITY(U,$J,358.3,30113,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,30113,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,30114,0)
 ;;=N76.3^^189^1906^20
 ;;^UTILITY(U,$J,358.3,30114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30114,1,3,0)
 ;;=3^Subacute/Chronic Vulvitis
 ;;^UTILITY(U,$J,358.3,30114,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,30114,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,30115,0)
 ;;=N80.9^^189^1906^6
 ;;^UTILITY(U,$J,358.3,30115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30115,1,3,0)
 ;;=3^Endometriosis,Unspec
 ;;^UTILITY(U,$J,358.3,30115,1,4,0)
 ;;=4^N80.9
 ;;^UTILITY(U,$J,358.3,30115,2)
 ;;=^5015837
 ;;^UTILITY(U,$J,358.3,30116,0)
 ;;=N81.5^^189^1906^21
 ;;^UTILITY(U,$J,358.3,30116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30116,1,3,0)
 ;;=3^Vaginal Enterocele
 ;;^UTILITY(U,$J,358.3,30116,1,4,0)
 ;;=4^N81.5
 ;;^UTILITY(U,$J,358.3,30116,2)
 ;;=^5015842
 ;;^UTILITY(U,$J,358.3,30117,0)
 ;;=N81.9^^189^1906^8
 ;;^UTILITY(U,$J,358.3,30117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30117,1,3,0)
 ;;=3^Female Genital Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,30117,1,4,0)
 ;;=4^N81.9
 ;;^UTILITY(U,$J,358.3,30117,2)
 ;;=^5015845
 ;;^UTILITY(U,$J,358.3,30118,0)
 ;;=N89.7^^189^1906^9
 ;;^UTILITY(U,$J,358.3,30118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30118,1,3,0)
 ;;=3^Hematocolpos
 ;;^UTILITY(U,$J,358.3,30118,1,4,0)
 ;;=4^N89.7
 ;;^UTILITY(U,$J,358.3,30118,2)
 ;;=^5015889
 ;;^UTILITY(U,$J,358.3,30119,0)
 ;;=N92.0^^189^1906^7
 ;;^UTILITY(U,$J,358.3,30119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30119,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Regular Cycle
 ;;^UTILITY(U,$J,358.3,30119,1,4,0)
 ;;=4^N92.0
 ;;^UTILITY(U,$J,358.3,30119,2)
 ;;=^5015908
 ;;^UTILITY(U,$J,358.3,30120,0)
 ;;=N92.5^^189^1906^10
 ;;^UTILITY(U,$J,358.3,30120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30120,1,3,0)
 ;;=3^Irregular Menstruation NEC
